octaplex innrennslisstofn og leysir, lausn 500 a.e.
octapharma ab - factor ii human; factor vii human; factor ix human; factor x human; protein c; protein s - innrennslisstofn og leysir, lausn - 500 a.e.
cefuroxim navamedic (cefuroxim villerton) stungulyfsstofn, lausn/dreifa 250 mg
navamedic asa - cefuroximum natríum - stungulyfsstofn, lausn/dreifa - 250 mg
cernevit stungulyfsstofn, lausn
baxter medical ab* - vítamín a (palmítat); colecalciferolum inn; vítamín e (tocoferolum nfn); acidum ascorbicum inn; thiaminum cocarboxylase tetrahýdrat; riboflavinum natríumfosfat díhýdrat; pyridoxinum hýdróklóríð; cyanocobalaminum inn; acidum folicum inn; dexpanthenolum inn; biotinum inn; nicotinamidum inn - stungulyfsstofn, lausn
lioresal stungulyf/innrennslislyf, lausn 0,5 mg/ml
novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 0,5 mg/ml
lioresal stungulyf/innrennslislyf, lausn 2 mg/ml
novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 2 mg/ml
lioresal stungulyf/innrennslislyf, lausn 50 míkróg/ml
novartis healthcare a/s - baclofenum inn - stungulyf/innrennslislyf, lausn - 50 míkróg/ml
fludarabin actavis stungulyfs-/innrennslisþykkni, lausn 25 mg/ml
actavis group ptc ehf. - fludarabinum fosfat - stungulyfs-/innrennslisþykkni, lausn - 25 mg/ml
protaminsulphat leo pharma stungulyf, lausn 10 mg/ml
leo pharma a/s* - protamini sulfas inn - stungulyf, lausn - 10 mg/ml
haldol stungulyf, lausn 5 mg/ml
essential pharma limited - haloperidolum inn - stungulyf, lausn - 5 mg/ml
fibryga stungulyfs-/innrennslisstofn og leysir, lausn 1 g
octapharma ab - human fibrinogen - stungulyfs-/innrennslisstofn og leysir, lausn - 1 g